Literature DB >> 10400633

The carboxyl tail of protease-activated receptor-1 is required for chemotaxis. Correlation of signal termination and directional migration.

G R Sambrano1, S R Coughlin.   

Abstract

The G protein-coupled thrombin receptor, protease-activated receptor 1 (PAR1), mediates many of the actions of thrombin on cells including chemotaxis. In contrast to the reversible agonist binding that regulates signaling by most G protein-coupled receptors (GPCRs), PAR1 is activated by an irreversible proteolytic mechanism. Although activated PAR1 is phosphorylated, uncoupled, and internalized like typical GPCRs, signal termination is additionally dependent on lysosomal degradation of cleaved and activated receptors. In the present study we exploit two PAR1 mutants to examine the link between chemotaxis and receptor shutoff. One, a carboxyl tail deletion mutant (Y397Z), is defective in phosphorylation and internalization. The other, a carboxyl tail chimeric receptor (P/S), is phosphorylated and internalized upon activation but recycles to the plasma membrane like reversibly activated GPCRs. Expression of these receptors in a hematopoietic cell line disrupted cell migration along thrombin gradients. Thrombin activation of cells expressing P/S or Y397Z resulted in persistent signaling independent of the continued presence of thrombin. Signaling in response to the soluble agonist peptide SFLLRN was reversible for P/S but persisted for Y397Z. Strikingly, cells expressing P/S responded chemokinetically to thrombin but chemotactically to SFLLRN. In contrast, Y397Z-mediated migration was largely chemokinetic to both agonists. These studies suggest that termination of PAR1 signaling at the level of the receptor is necessary for gradient detection and directional migration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400633     DOI: 10.1074/jbc.274.29.20178

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The IL sequence in the LLKIL motif in CXCR2 is required for full ligand-induced activation of Erk, Akt, and chemotaxis in HL60 cells.

Authors:  Jiqing Sai; Glenn Walker; John Wikswo; Ann Richmond
Journal:  J Biol Chem       Date:  2006-09-20       Impact factor: 5.157

Review 2.  Chemokine receptor internalization and intracellular trafficking.

Authors:  Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-05       Impact factor: 7.638

3.  Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton.

Authors:  V B Mahajan; K S Pai; A Lau; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

4.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.

Authors:  C Tiruppathi; W Yan; R Sandoval; T Naqvi; A N Pronin; J L Benovic; A B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

5.  Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.

Authors:  Huilan Lin; JoAnn Trejo
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

6.  The C-terminal domain LLKIL motif of CXCR2 is required for ligand-mediated polarization of early signals during chemotaxis.

Authors:  Jiqing Sai; Guo-Huang Fan; Dingzhi Wang; Ann Richmond
Journal:  J Cell Sci       Date:  2004-10-12       Impact factor: 5.285

7.  Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion.

Authors:  Michelle A Booden; Lynn B Eckert; Channing J Der; JoAnn Trejo
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

8.  RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.

Authors:  Jane A C Wilson; Natalie A Prow; Wayne A Schroder; Jonathan J Ellis; Helen E Cumming; Linden J Gearing; Yee Suan Poo; Adam Taylor; Paul J Hertzog; Francesca Di Giallonardo; Linda Hueston; Roger Le Grand; Bing Tang; Thuy T Le; Joy Gardner; Suresh Mahalingam; Pierre Roques; Phillip I Bird; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2017-02-16       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.